Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
0.7716
-0.0176 (-2.23%)
Nov 20, 2026, 4:00 PM EST - Market closed
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $100.16 million as of November 20, 2026. It is the 24,551st most valuable company in the world and the 3,977th biggest in the United States. Its market cap has decreased by 84.62% in one year.
Market Cap
100.16M
Enterprise Value
143.35M
1-Year Change
-84.62%
Global Rank
Country Rank
#3,977 United States
Category
ChartMarket Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $100.16M, a decrease of -91.90%. That is a compound annual growth rate of -27.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 100.16M | -84.77% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 201.19M |
| ADC Therapeutics | 192.71M |
| Anika Therapeutics | 182.44M |
| Glass House Brands | 129.11M |
| Akebia Therapeutics | 113.54M |
| Cardiol Therapeutics | 110.86M |
| Journey Medical | 104.15M |
| BGM Group | 103.09M |